Whilst not trying to sound callous, I'd assume these patients, having advanced cancers that had not reacted favourably to previous treatments, would be in fairly poor state of health before commencing this radio-therapy trial? Clearly that must have significant deleterious impact on the survival rate regardless of how good the Cu67 treatment may be?
Any doctor care to respond?
- Forums
- ASX - By Stock
- CU6
- Research/Valuation
Research/Valuation, page-516
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$6.03 |
Change
-0.270(4.29%) |
Mkt cap ! $1.899B |
Open | High | Low | Value | Volume |
$6.30 | $6.45 | $5.65 | $13.43M | 2.223M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 14784 | $5.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.04 | 4000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 5.960 |
2 | 5253 | 5.900 |
1 | 85 | 5.790 |
1 | 3 | 5.780 |
1 | 740 | 5.750 |
Price($) | Vol. | No. |
---|---|---|
6.040 | 4000 | 2 |
6.060 | 2000 | 1 |
6.100 | 86 | 1 |
6.170 | 4234 | 1 |
6.190 | 1500 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |